INVOLVEMENT OF COMPLEMENT IN PSORIASIS AND ATOPIC-DERMATITIS - MEASUREMENT OF C3A AND C5A, C-3, C-4 AND C1 INACTIVATOR
INVOLVEMENT OF COMPLEMENT IN PSORIASIS AND ATOPIC-DERMATITIS - MEASUREMENT OF C3A AND C5A, C-3, C-4 AND C1 INACTIVATOR
复制标题
DOI:
10.1007/bf00509233
复制
发表时间:
1985-01-01
影响因子:
3
通讯作者:
SCHOPF, E
中科院分区:
文献类型:
--
作者:
KAPP, A;WOKALEK, H;SCHOPF, E
Normal complement [C] components and activation products were determined in the peripheral blood of 35 patients with atopic dermatitis (AD) and 24 patients with psoriasis at a mild to intermediate stage. No patients received systemic or local steroid therapy 6 wk prior to blood collection. Levels of C3, C4 and C1 inactivator (C1 INA) were determined in serum by radial immunodiffusion; C3a and C5a levels were measured by radioimmunoassay. In comparison to healthy nonatopic controls, the levels of C3, C4 and C1 INA were found to be significantly increased in both diseases. No substantial differences were detected between patients with psoriasis vulgaris and psoriasis guttata, which suggests that the dissimilarities found were not due to preceding or concomitant infections. In AD, there was a tendency towards increased C3a levels; in psoriasis, C3a levels were significantly increased. In both diseases, no measurable amounts of C5a could be detected. In AD and psoriasis, the complement evidently participates in the inflammatory process. Elevated levels of C3a suggest that there is a continuous activation of the complement system leading to the generation of inflammatory mediators.